PF4V1, an miRNA-875-3p target, suppresses cell proliferation, migration, and invasion in prostate cancer and serves as a potential prognostic biomarker

References

• DaniyalMSiddiquiZAAkramMAsifHMSultanaSKhanAEpidemiology, etiology, diagnosis and treatment of prostate cancerAsian Pac J Cancer Prev201415229575957825520069
   PubMedGoogle Scholar
• TaoZ-QShiA-MWangK-XZhangW-DEpidemiology of prostate cancer: current statusEur Rev Med Pharmacol Sci201519580581225807434
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• LiDHaoXLiJDose-response relation between dietary inflammatory index and human cancer risk: evidence from 44 epidemiologic studies involving 1,082,092 participantsAm J Clin Nutr2018107337138829566194
   PubMed Web of Science ®Google Scholar
• LiDLvHHaoXDongYDaiHSongYPrognostic value of bone scan index as an imaging biomarker in metastatic prostate cancer: a meta-analysisOncotarget2017848844498445829137438
   PubMedGoogle Scholar
• ZhangMChenLYuanZCombined serum and EPS-urine proteomic analysis using iTRAQ technology for discovery of potential prostate Cancer biomarkersDiscov Med20162212228129528009970
   PubMed Web of Science ®Google Scholar
• ZhangNZhangHLiuYSREBP1, targeted by miR-18a-5p modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with snail and HDAC1/2Cell Death Differ201866
   Google Scholar
• HausserJZavolanMIdentification and consequences of miRNA-target interactions – beyond repression of gene expressionNat Rev Genet201415959961225022902
   PubMed Web of Science ®Google Scholar
• SvoronosAAEngelmanDMSlackFJOncomiR or tumor suppressor? The Duplicity of microRNAs in cancerCancer Res201676133666367027325641
   PubMed Web of Science ®Google Scholar
• KanwalRPlagaARLiuXShuklaGCGuptaSMicroRNAs in prostate cancer: functional role as biomarkersCancer Lett201740792028823964
   PubMed Web of Science ®Google Scholar
• MassilloCDaltonGNFarréPLde LucaPde SierviAImplications of microRNA dysregulation in the development of prostate cancerReproduction20171544R81R9728878093
   PubMed Web of Science ®Google Scholar
• WangPLiuXMDingLZhangXJMaZLmTOR signaling-related microRNAs and cancer involvementJ Cancer20189466767329556324
   PubMed Web of Science ®Google Scholar
• LiDHaoXSongYAn integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancerOnco Targets Ther2018113075308529872319
   PubMed Web of Science ®Google Scholar
• LiDHaoXSongYIdentification of the key microRNAs and the miRNA-mRNA regulatory pathways in prostate cancer by bioinformatics methodsBiomed Res Int2018201848110
   Google Scholar
• NervianiAPitzalisCRole of chemokines in ectopic lymphoid structures formation in autoimmunity and cancerJ Leukoc Biol2018104233334129947426
   PubMed Web of Science ®Google Scholar
• KotyzaJChemokines in tumor proximal fluidsBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub20171611414928115749
   PubMed Web of Science ®Google Scholar
• LeeHJSongI-CYunH-JJoD-YKimSCXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targetingWorld J Gastroenterol20142071681169324587647
   PubMed Web of Science ®Google Scholar
• VandercappellenJvan DammeJStruyfSThe role of CXC chemokines and their receptors in cancerCancer Lett2008267222624418579287
   PubMed Web of Science ®Google Scholar
• YangGRosenDGLiuGCXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesisClin Cancer Res201016153875388620505188
   PubMed Web of Science ®Google Scholar
• MeijerJZeelenbergISSiposBRoosEThe CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liverCancer Res200666199576958217018614
   PubMed Web of Science ®Google Scholar
• RuytinxPProostPStruyfSCXCL4 and CXCL4L1 in cancerCytokine2018109657129903575
   PubMed Web of Science ®Google Scholar
• FuruyaMTanakaRMiyagiEImpaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosisCancer Biol Ther201213867168022555803
   PubMed Web of Science ®Google Scholar
• van RaemdonckKBerghmansNVanheuleVAngiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer modelOncotarget2014521109161093325373734
   PubMedGoogle Scholar
• QuemenerCBaudJBoyéKDual roles for CXCL4 chemokines and CXCR3 in angiogenesis and invasion of pancreatic cancerCancer Res201676226507651927634764
   PubMed Web of Science ®Google Scholar
• HeSJXiangCQZhangYLuXTChenHWXiongLXRecent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transitionOnco Targets Ther2017103435345128744148
   PubMed Web of Science ®Google Scholar
• FangYXGaoWQRoles of microRNAs during prostatic tumorigenesis and tumor progressionOncogene201433213514723455326
   PubMed Web of Science ®Google Scholar
• FletcherCEDartDASita-LumsdenAChengHRenniePSBevanCLAndrogen-regulated processing of the oncomiR miR-27a, which targets prohibitin in prostate cancerHum Mol Genet201221143112312722505583
   PubMed Web of Science ®Google Scholar
• LuZLiuMStribinskisVMicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 geneOncogene200827314373437918372920
   PubMed Web of Science ®Google Scholar
• ClapéCFritzVHenriquetCmiR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in micePLoS One2009410e754219855844
   PubMed Web of Science ®Google Scholar
• El BezawyRCominettiDFendericoNmiR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axisCancer Lett2017395536228274892
   PubMed Web of Science ®Google Scholar
• LiDYHaoXYMaTMDaiHXSongYSThe prognostic value of platelet-to-lymphocyte ratio in urological cancers: a meta-analysisSci Rep2017711538729133845
   PubMedGoogle Scholar
• PratsACvan den BergheLRayssacACXCL4L1-fibstatin cooperation inhibits tumor angiogenesis, lymphangiogenesis and metastasisMicrovasc Res201389253323747987
   PubMed Web of Science ®Google Scholar
• StruyfSSalogniLBurdickMDAngiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3Blood2011117248048820980681
   PubMed Web of Science ®Google Scholar